Allen Andrew R is a director of Adaptimmune Therapeutics Plc.
Person profile
Roles
Address
Boulder, Colorado
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Gritstone bio, Inc.
17 May 24
4
Gritstone bio, Inc.
5 Feb 24
4
Adaptimmune Therapeutics PLC
5 Jul 23
4
Adaptimmune Therapeutics PLC
3 Jul 23
3
Adaptimmune Therapeutics PLC
1 Jun 23
4
TCR2 THERAPEUTICS INC.
1 Jun 23
4
Gritstone bio, Inc.
6 Feb 23
4
TCR2 THERAPEUTICS INC.
19 Dec 22
4
Sierra Oncology, Inc.
1 Jul 22
4
Gritstone bio, Inc.
20 Apr 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 May 24 | GRTS Gritstone Bio | Common Stock | Sell | Dispose S | No | No | 0.7483 | 24,263 | 18.16 k | 985,360 |
15 May 24 | GRTS Gritstone Bio | Common Stock | Grant | Acquire A | No | No | 0 | 47,873 | 0.00 | 1,009,623 |
15 May 24 | GRTS Gritstone Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 0.75 | 615,000 | 461.25 k | 615,000 |
1 Feb 24 | GRTS Gritstone Bio | Common Stock | Grant | Acquire A | No | No | 0 | 105,000 | 0.00 | 899,345 |
1 Feb 24 | GRTS Gritstone Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 2.46 | 615,000 | 1.51 mm | 615,000 |
3 Jul 23 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 500,000 | 80.00 k | 500,000 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 6.07 | 8,072 | 49.00 k | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.11 | 6,270 | 101.01 k | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 16.1 | 5,000 | 80.50 k | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 31.83 | 12,100 | 385.14 k | 0 |